Penpulimab, identified by the distinct CAS number 2350298-92-7, represents a cutting-edge clinical antibody currently undergoing research for its potential in tumor treatment. This biologic molecule is designed to bind https://maegjds012021.wikimidpoint.com/7272769/penpulimab_a_deep_investigation_into_the_2350298_92_7_immunoglobulin